Диссертация (1173252), страница 19
Текст из файла (страница 19)
J. Kim et al. // AJNR Am J Neuroradiol. – 2015. – Vol. 36.– P. 672–77.84.Rau, M. K. Prognostic value of blood flow estimated by arterial spinlabeling and dynamic susceptibility contrast-enhanced MR imaging in high-gradegliomas / M. K. Rau, C. Braun, M. et al. // J Neurooncol. – 2014. – Vol. 120. –P. 557–66.85.Reginster, P.
Comparative study of pseudo-continuous arterial spin labelingand dynamic susceptibility contrast imaging at 3.0 Tesla in brain tumors / P. Reginster,Bю Martin, V. Denolin // Neurooncol Open Access. – 2017. – Vol 2(1). – 13 p.86.Rosen, B. R. Perfusion imaging with NMR contrast agents / B.
R. Rosen, J.W. Belliveau, J. M. Vevea et al. // Magn Reson Med. – 1990. – Vol. 14. – P. 249-265.12187.Roy, B. Comparative evaluation of 3-dimensional pseudocontinuousarterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonanceimaging in grading of human glioma / B. Roy, R. Awasthi, A. Bindal et al. // J ComputAssist Tomogr. – 2013. – Vol. 37. – P. 321–26.88.Roy, B. Utility of multiparametric 3-T MRI for glioma characterization / B.Roy, R.
K. Gupta, A. A. Maudsley et al. // Neuroradiology. – 2013. – Vol. 55. – P. 603–13.89.Sandson, T. A. Noninvasive perfusion MRI in Alzheimer's disease: apreliminary report / T. A. Sandson, M. O'Connor, R. A. Sperling et al. Neurology. –1996. – Vol. 47. – P. 1339-1342.90.Schmidt, R. MRI in dementia / R. Schmidt, D. Havas, S. Ropele et al. //Neurol Clin. – 2009. – Vol. 27. – P. 221-236.91.Schwartzbaum, J. A. Epidemiology and molecular pathology of glioma / J.A.
Schwartzbaum, J. L. Fisher, K. D. Aldape et al. // Nat Clin Pract Neurol. – 2006. –Vol. 2. – P. 494-503.92.Sjoblom, T. The consensus coding sequences of human breast andcolorectal cancers / T. Sjoblom, S. Jones, L. D. Wood et al. // Science. – 2006. – Vol.314. – P. 268–274.93.Soffietti, R. European Federation of Neurological Societies. Guidelines onthe management of low-grade gliomas: report of an EFNS-EANO Task Force / R.Soffietti, B. G. Baumert, L. Bello et al. // Eur J Neurol.
– 2010. – Vol. 17. – P. 1124–33.94.Stepp, H. ALA and malignant glioma: fluorescence-guided resection andphotodynamic treatment / H. Stepp, T. Beck, T. Pongratz et al. // J Environ PatholToxicol Oncol. – 2007. – Vol. 26(2). – P. 157-64.95.Stummer, W. Fluorescence-guided resection of glioblastoma multi-forme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52consecutive patients / W. Stummer, A. Novotny, H. Stepp et al.
// J Neurosurg. – 2000.– Vol. 93. – P. 1003–1013.12296.Stummer, W. Fluorescence-guided surgery with 5-aminolevulinic acid forresection of malignant glioma: a randomized controlled multicentre phase III trial / W.Stummer, U. Pichlmeier, T. Meinel et al //Lancet Oncol. – 2007. – Vol. 7. – P. 392–401.97.Toth, R.
K. Strange bedfellows: nuclear factor, erythroid 2-like 2 (Nrf2)and hypoxia-inducible factor 1 (HIF-1) in tumor hypoxia / R. K. Toth, N. A. Warfel //Antioxidants. – 2017. – Vol. 6. – 27 p.98.Tourdias, T. Pulsed arterial spin labeling applications in brain tumors:practical review / T. Tourdias, S. Rodrigo, C. Oppenheim et al. // J Neuroradiol. – 2008.– Vol. 35.
– P. 79-89.99.Valdés, P. A. Combined fluorescence and reflectance spectroscopy for invivo quantification of cancer biomarkers in low- and high-grade glioma surgery / P. A.Valdés, A. Kim, F. Leblond et al. // J Biomed Opt. – 2011. – Vol. 16(11). – 14 p.100. van Gelderen, P. Pittfalls of MRI measurement of white matter perfusionbased on arterial spin labeling / P. van Gelderen, J. A.
de Zwart, J. H. Duyn // MagnReson Med. – 2008. – Vol. 59. – P. 788-795.101. van Laar, P. J. Brain perfusion territory imaging: methods and clinicalapplications of selective arterial spin-labeling MR imaging / P. J. van Laar, J. van derGrond, J. Hendrikse // Radiology. – 2008. – Vol. 246. – P. 354-364.102.
van Osch, M. J. Can arterial spin labeling detect white matter perfusionsignal? / M. J. van Osch, W. M. Teeuwisse, M. A. van Walderveen et al. // Magn ResonMed. – 2009. – Vol. 62. – P. 165-173.103. Wang, J. Pediatric perfusion imaging using pulsed arterial spin labeling / J.Wang, D. J. Licht, G. H. Jahng et al. // J Magn Reson Imaging. – 2003. – Vol. 18. – P.404-413.104. Wang, J. Pediatric perfusion MR imaging using arterial spin labeling / J.Wang, D. J. Licht // Neuroimaging Clin N Am.
– 2006. – Vol. 16. – P. 149-167105. Ward, P. S. The common feature of leukemia-associated IDH1 and IDH2mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-123hydroxyglutarate / P. S. Ward, J. Patel, D. R. Wise, et al. // Cancer Cell. – 2010. – Vol.17(3). – P. 225–234.106. Warmuth, C. Quantification of blood flow in brain tumors: comparison ofarterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MRimaging / C. Warmuth, M. Gunther, C. Zimmer // Radiology.
– 2003. – Vol. 228. – P.523–32.107. Watanabe, T. IDH1 mutations are early events in the development ofastrocytomas and oligodendrogliomas / T. Watanabe, S. Nobusawa, P. Kleihues // Am JPathol. – 2009. – Vol. 174(4). – P. 1149–1153.108. Weber, M. A. Comparison of arterial spin-labeling techniques and dynamicsusceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal braintissue / M.
A. Weber, M. Günther, M. P. Lichy. // Invest Radiol. – 2003. – Vol. 38. – P.712-718.109. Weber, M. A. Assessment of irradiated brain metastases by means ofarterial spin-labeling and dynamic susceptibility weighted contrast-enhanced perfusionMRI: initial results / M. A. Weber, C. Thilmann, M. P. Lichy // Invest Radiol. – 2004. –Vol.
39. – P. 277-287.110. Weller, M. European Association for Neuro-Oncology(EANO) Task Forceon Malignant Glioma. EANO guideline for the diagnosis and treatment of anaplasticgliomas and glioblastoma / M. Weller, M. van den Bent, K. Hopkins et al. // LancetOncol. – 2014. – Vol.15. – e395– e403.111. Widhalm, G. Strong 5-aminolevulinic acid-induced fluorescence is a novelintraoperative marker for representative tissue samples in stereotactic brain tumorbiopsies / G. Widhalm, G. Minchev, A. Woehrer et al. // Neurosurg Rev. – 2012.
– Vol.35(3). – P. 381-91.112. Williams, D. S. Magnetic resonance imaging of perfusion using spininversion of arterial water / D. S. Williams, J. A. Detre, J. S. Leigh et al. // Proc NatlAcad Sci USA. – 1992. – Vol. 89. – P. 212-216.124113. Wolf, R. L. Clinical neuroimaging using arterial spin labeled perfusionmagnetic resonance imaging / R. L. Wolf, J. A. Detre // Neurotherapeutics.
– 2007. –Vol. 4. – P. 346-359.114. Wolf, R. L.Arteriovenousshuntvisualizationinarteriovenousmalformations with arterial spin-labeling MR imaging / R. L. Wolf, J. Wang, J. A.Detre et al. // AJNR Am J Neuroradiol. – 2008. – Vol. 29. – P. 681-687.115. Wolf, R. L. Grading of CNS neoplasms using continuous arterial spinlabeled perfusion MR imaging at 3 Tesla / R. L. Wolf, J. Wang, S. Wang et al. // JMagn Reson Imaging. – 2005.
– Vol. 22. – P. 475– 82.116. Wong, E. C. Velocity-selective arterial spin labeling / E. C. Wong, M.Cronin, W. C. Wu et al. // Magn Reson Med. – 2006. – Vol. 55. – P. 1334-1341.117. Wong, E. C. New developments in arterial spin labeling pulse sequences /E. C. Wong // NMR Biomed. – 2013. – Vol. 26. – P. 887–91.118. Wong, E. C. Quantifying CBF with pulsed ASL: technical and pulsesequence factors / E.
C. Wong // J Magn Reson Imaging. – 2005. – Vol. 22. – P. 727731.119. Wu, B. Collateral circulation imaging: MR perfusion territory arterial spinlabeling at 3T / B. Wu, X. Wang, J. Guo et al. // AJNR Am J Neuroradiol. – 2008. –Vol. 29. – P. 1855-1860.120. Wu, W. C.
A theoretical and experimental investigation of the taggingefficiency of pseudocontinuous arterial spin labeling / W. C. Wu, M. Fernández-Seara,J. A. Detre et al. // Magn Reson Med. – 2007. – Vol. 58. – P. 1020-1027.121. Wu, W. C. Intravascular effect in velocity-selective arterial spin labeling:the choice of inflow time and cutoff velocity / W. C. Wu, E. C. Wong // Neuroimage. –2006.
– Vol. 32. – P. 122-128.122. Xiao, H. Astrocytic tumour grading: a comparative study of threedimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrastenhanced perfusion-weighted imaging, and diffusion-weighted imaging / H. Xiao, Z.Chen, X. Lou et al. // Eur Radiol. – 2015.
– Vol. 25. – P. 3423–30.125123. Yamashita, K. MR Imaging–Based Analysis of Glioblastoma Multiforme:Estimation ofIDH1Mutation Status / K. Yamashita, A. Hiwatashi, O. Togao et al. //American Journal of Neuroradiology. – 2015. – Vol. 37(1). – P. 58-65.124. Yan, H. IDH1 and IDH2 mutations in gliomas / H. Yan, D. W.
Parsons, G.Jin et al. N Engl J Med. – 2009. – Vol. 360(8). – P. 765–773.125. Yang, S. Improving the Grading Accuracy of Astrocytic NeoplasmsNoninvasively by Combining Timing Information with Cerebral Blood Flow: A MultiTI Arterial Spin-Labeling MR Imaging Study / S. Yang, Bю Zhao, G. Wang et al. //AJNR Am J Neuroradiol. – 2016. – Vol. 37. – P. 2209–16.126. Zagzag, D.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
